Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

A novel receptor-targeted gene delivery system for cancer gene therapy

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

A Novel Gene Delivery System Targeting Cells Expressing VEGF Receptors

A novel gene delivery system targeting Tie2 for cancer gene therapy.

Construction of an EGF receptor-mediated histone H1 0 -based gene delivery system

Construction of an EGF receptor-mediated histone H10-based gene delivery system

Systemic genetic transfer of p21 WAF − 1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex

Gene Delivery Using a Receptor-Mediated Gene Transfer System Targeted to Hepatocellular Carcinoma Cells.

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

Construction Of A Tumor Cell-Targeting Non-Viral Gene Delivery Vector With Polyethylenimine Modified With Rgd Sequence-Containing Peptide

Redox-Responsive Multifunctional Polypeptides Conjugated with Au Nanoparticles for Tumor-Targeting Gene Therapy and Their 1+1 > 2 Synergistic Effects

A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers.

Ultrasensitive Ph Triggered Charge/Size Dual-Rebound Gene Delivery System

Virus-esque nucleus-targeting nanoparticles deliver trojan plasmid for release of anti-tumor shuttle protein.

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.

Arginine-rich Peptide Based Nanoparticles with Bridge-Like Structure: Enhanced Cell Penetration and Tumor Therapy Effect

Novel Gelatin-Siloxane Nanoparticles Decorated By Tat Peptide As Vectors For Gene Therapy

A Cancer Cell Membrane Coated Nanoparticles-Based Gene Delivery System for Enhancing Cancer Therapy

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-γ-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector

Enhanced Antitumor Effect of EGF R–targeted P21waf-1 and GM-CSF Gene Transfer in the Established Murine Hepatoma by Peritumoral Injection

Peptide-based vectors mediated by avidin-biotin interaction for tumor targeted gene delivery